Earlier this year we met our goal of enrolling 1,000 people in a community of people with a collection of rare blood disorders known as myeloproliferative neoplasms, or MPNs. Since then we’ve been able to replicate known genetic associations with these rare disorders, as well as make new findings of our [...]
